Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-23
1997-03-04
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514465, 514653, 549407, 549438, 564172, C07D31104, A01K 3135
Patent
active
056079664
ABSTRACT:
Compounds having anti-inflammatory and anti-oxidant activity are disclosed. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms. Methods of treatment employing these properties of the compounds and corresponding pharmaceutical compositions are disclosed.
REFERENCES:
patent: 4374258 (1983-02-01), Horner
patent: 4988728 (1991-01-01), Gerson et al.
patent: 5084575 (1992-01-01), Kreft, III et al.
Hammond et al., "2,3-Dihydro-5-benzofuranols as Antiooxidant-Based Inhibitors of Leukotriene Biosynthesis", J. Med. Chem., vol. 32, pp. 1006-1020 (1989).
Hutchinson et al., "Drug Discovery and Development through the Genetic Engineering of Antibiotic-Producing Microorganisms", Journal of Medicinal Chemistry, vol. 32, No. 5, pp. 907-918 (1989).
Tseng, C., et al., "Inhibition of in Vitro Prostaglandin and Leukotriene Biosyntheses by Chinnamoyl-.beta.-phenethylamine and N-Acyidopamine Derivatives", Chem. Pharm. Bull., vol. 40, No. 2, pp. 396-400 (1992).
Campbell, W.; "Lipid-Derived Autacoids"; Goodman and Gilman's The Pharmacological Basis of Therapeutics, Pergman Press, New York (1990) 600-617.
Gifford, H.; "The Treatment of Sympathetic Ophthalmia"; Ophthalmoscope 8 (1910) 257-259.
Goa and Chrisp; "Ocular Diclofenac"; Drugs & Aging 2(6) (1992) 473-486.
Insel, P.; "Analgesic-Antipyretics and Antiinfmammatory Agents"; Goodman and Gilman's The Pharmacological Basis of Therapeutics; Pergman Press, New York (1990) 638-669, 681.
"Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities"; Biochemical Pharmacology 32 (14) (1983) 2283-2286.
Bellavite, P.; "The Superoxide-Forming Enzymatic System of Phagocytes"; Free Radical Biology & Medicine 4 (1988) 255-261.
Duchstein and Gurka; "Activated Species of Oxygen"; Archives of Pharmacology 325 (1992) 129-146.
Sies and Murphy, "Role of tocopherols in the protection of biological systems against oxidative damage"; Journal of Photochemistry and Photobiology 8 (1991) 211-224.
Chow, C.; "Vitamin E and Oxidative Stress"; Free Radical Biology & Medicine 11 (1991) 215-232.
Petty, et al.; "Protective Effects of an .alpha.-tocopherol analogue against myocardial reperfusion injury in rats"; European Journal of Pharmacology 210 (1992) 85-90.
Bonne, et al.; "2-(2-Hydroxy-4-methylphenyl)aminothiazole Hydrochloride as a Dual Inhibitor of Cyclooxygenase/Lipoxygenzse and a Free Radical Scavenger"; Drug Research 39 II, Nr. 10 (1989) 1242-1245.
Nelson, P.; "Cyclooxygenase Inhibitors"; CRC Handbook of Eicosanoids: Prostaglandins, and Related Lipids, vol. II Drugs Acting Via the Eicosanoids; CRC Press, Boca Raton, FL (1989) 59-133.
Cohen, et al.; "Lewis Acid Mediated Nucleophilic Substitution Reactions"; Journal of Organic Chemistry 54 (1989) 3282-3292.
Lambda, et al.; "Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system"; Biochimica et Biophysica Acta 1081 (1991) 181-187.
Skoog and Beck; "Methods of Isolating Leukocytes"; Blood 11 (1956) 436-454.
Graff and Anderson; "1-[4-[3-[4-[BIS(4-Fluorophenyl)hydroxymethyl]-1-peperidinyl]propoxy]-3-me thoxyphenyl]ethanone (AHR-5333)"; Prostaglandins 38 No. 4 (1989) 473-497.
Bazan. H.; "Response of Inflammatory Lipid Mediators following Corneal Injury"; Lipid Mediators in Eye Inflammation.
New Trends Lipid Mediators Res. Basel Karger vol. 5 (1990) 1-11.
Graff Gustav
Hellberg Mark R.
Alcon Laboratories Inc.
Brown Gregg C.
Gerstl Robert
Mayo Michael C.
LandOfFree
Esters and amides of non-steroidal anti-inflammatory carboxylic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters and amides of non-steroidal anti-inflammatory carboxylic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters and amides of non-steroidal anti-inflammatory carboxylic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146280